Elizabeth Fowler, Ph.D, J.D.
Deputy Administrator and Director
Center for Medicare and Medicaid Innovation
Centers for Medicare & Medicaid Services
Letters
Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Latest
AHA's comment on the Centers for Medicare & Medicaid Services鈥 calendar year 2022 proposed rule for the HH prospective payment system.
AHA raises 鈥渟ubstantial concerns鈥 with the prototype payment model that the Centers for Medicare & Medicaid Services, Department of Health and Human Services Assistant Secretary for Planning and Evaluation, and RTI International are developing for the new unified post-acute care prospective payment system required by the Improving Medicare Post-Acute Care Transformation Act of 2014.
AHA鈥檚 comments to OSHA on the agency鈥檚 COVID-19 Emergency Temporary Standard.
President Biden鈥檚 Executive Order on Promoting Competition in the American Economy called upon all agencies of the federal government to protect and promote fair competition throughout the economy. Achieving that objective will require each agency to assess fairly the activities of those fields and industries that fall within its purview.
President Biden鈥檚 Executive Order on Promoting Competition in the American Economy called upon all agencies of the federal government to protect and promote fair competition throughout the economy. Achieving that objective will require each agency to assess fairly the activities of those fields and industries that fall within its purview.
The Honorable Xavier Becerra
Secretary
U.S. Department of Health and Human Services
200 Independence Avenue, S.W.
Washington, D.C. 20201
AHA model comments on OSHA鈥檚 COVID-19 Emergency Temporary Standard.
This letter provides comment on the Centers for Medicare & Medicaid Services鈥 guidance documents implementing the No Surprises Act鈥檚 provisions related to notice and consent and public disclosure.
Letter to the Department of Justice鈥檚 Antitrust Division on the adequacy of any potential remedies to resolve the substantial competitive concerns raised by UnitedHealth Group鈥檚 proposed acquisition of Change Healthcare.